Skip to content

Feed Screener Search Methodology

SEC · FI · BAFIN · AFM · AMF

Pricing Sign in

InsiderLens

Statistics predict. AI explains.

Insider transactions from public regulatory disclosures, aggregated and enriched with deterministic statistical signals. Not investment advice.

Sources

SEC EDGAR · US
FINANSINSPEKTIONEN · SE
BAFIN · DE
AFM · NL
AMF · FR

Product

Methodology
Privacy notice
Object to processing

Feed Screener Search Methodology

Pricing Sign in

Nikolaou Anastasis — Acrivon Therapeutics, Inc. insider: 1 transactions · InsiderLens

Home / Insiders / Nikolaou Anastasis

Nikolaou Anastasis

10% owner at Acrivon Therapeutics, Inc. · on record since Nov 21, 2022

Insider trading activity of Nikolaou Anastasis

Transactions on record: 1; since Jun 20, 2023

Open-market buys: 0

Open-market sells: 1; $25K

Companies traded: 1; last filing Jun 20, 2023

Figures computed from official regulatory filings — methodology.

Companies where Nikolaou Anastasis has traded

Acrivon Therapeutics, Inc.1 tx · $25K · Jun 20, 2023

Track record of Nikolaou Anastasis

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Nikolaou Anastasis

Co-insiders of Nikolaou Anastasis

BAUM CHARLES MAcrivon Therapeutics, Inc.
Blume-Jensen PeterAcrivon Therapeutics, Inc.
Chione LtdAcrivon Therapeutics, Inc.
Cuillerot Jean-MarieAcrivon Therapeutics, Inc.
Czernik MarcinAcrivon Therapeutics, Inc.
Devroe EricAcrivon Therapeutics, Inc.
DiRocco DerekAcrivon Therapeutics, Inc.

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

EDELMAN JOSEPHAcrivon Therapeutics, Inc.

Gamelin ErickAcrivon Therapeutics, Inc.

Hadjimichael AndreasAcrivon Therapeutics, Inc.

Holm-Jorgensen RasmusAcrivon Therapeutics, Inc.

Kolchinsky PeterAcrivon Therapeutics, Inc.

Levy Adam D.Acrivon Therapeutics, Inc.

Magovcevic IvanaAcrivon Therapeutics, Inc.

Masson KristinaAcrivon Therapeutics, Inc.

Miller MaryAcrivon Therapeutics, Inc.

Mirza Mansoor RazaAcrivon Therapeutics, Inc.

Palani SanthoshAcrivon Therapeutics, Inc.

PERCEPTIVE ADVISORS LLCAcrivon Therapeutics, Inc.

PERCEPTIVE LIFE SCIENCES MASTER FUND LTDAcrivon Therapeutics, Inc.

Peterson KatharineAcrivon Therapeutics, Inc.

RA Capital Biotech Fund LPAcrivon Therapeutics, Inc.

RA CAPITAL MANAGEMENT, LLCAcrivon Therapeutics, Inc.

RA Capital Nexus Fund II, L.P.Acrivon Therapeutics, Inc.

Shacham SharonAcrivon Therapeutics, Inc.

Shah Rajeev M.Acrivon Therapeutics, Inc.

Smolokowski WiaczeslawAcrivon Therapeutics, Inc.

TOMSICEK MICHAEL JOHNAcrivon Therapeutics, Inc.

Wellington Biomedical Innovation Master Investors (Cayman) I L.P.Acrivon Therapeutics, Inc.

Company	Filed	Type	Qty	Price	Value · USD	Src
Acrivon Therapeutics, Inc.	Jun 20, 2023	Sell	-2,056	12.14 USD	$25K	SEC